Tamer I. Khayal, Chief Commercial Officer at TransMedics Group, Inc. (TMDX), sold 4,304 shares at $146.15 ($637K) on 2024-10-01, disclosed to the SEC on 2024-10-03.
Scheduled sale ($637k) by Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $146.15 | 823 | $120K | 18.9% |
| 2 | $146.15 | 823 | $120K | 18.9% |
| 3 | $146.90 | 900 | $132K | 20.8% |
| 4 | $147.98 | 80 | $12K | 1.9% |
| 5 | $149.59 | 523 | $78K | 12.3% |
| 6 | $149.59 | 523 |
| $78K |
| 12.3% |
| 7 | $150.38 | 318 | $48K | 7.5% |
| 8 | $151.20 | 80 | $12K | 1.9% |
| 9 | $152.28 | 80 | $12K | 1.9% |
| 10 | $153.75 | 20 | $3K | 0.5% |
| 11 | $154.86 | 134 | $21K | 3.3% |
| Total | $148.00 avg | 4,304 | $637K | 100% |
| Filing → |
| TMDX | SELL | 2024-12-04 | $187K | — | Filing → |
| TMDX | SELL | 2024-11-13 | $263K | — | Filing → |
| TMDX | SELL | 2024-11-05 | $179K | — | Filing → |